Retour aux projets

25617.1 PFLS-LS

Validation and optimiztion of a screening platform for the study of liver disease (fibrosis and NASH)

Résumé

Validation and optimiztion of a screening platform for the study of liver disease (fibrosis and NASH)

Textes supplémentaires

Abstract

Within the CTI Project No. 16856.1 PFLS-LS we successfully implemented a human in vitro model containing functional hepatocytes, Kupffer and stellate cells for the investigation of liver fibrosis. In this follow-up project, we aim at validating the model with additional pro-fibrotic and antifibrotic stimuli. We will also assess the suitablity of the system for the investigation of NASH and its relationship with fibrosis. In addition, we will implement shipping tests for the product.

Participants

David Fluri

Wirtschaftspartner

david.fluri@insphero.com

InSphero AG CHE-114.790.768 David Fluri Wagistrasse 27 8952 Schlieren ZH CH

Laura Suter-Dick

Kontaktperson

Laura.suterdick@fhnw.ch

FHNW Fachhochschule Nordwestschweiz Hochschule für Life Sciences Laura Suter-Dick Gründenstrasse 40 4132 Muttenz BL CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2017-04-30
Date de fin
2018-08-31
Coûts totaux approuvés
CHF 162809.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%